rs587783241
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 3P and 5B. PM2PM4_SupportingBP6BS1
The NM_018136.5(ASPM):c.4118_4120delATT(p.Tyr1373del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000291 in 1,608,852 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. Y1373Y) has been classified as Likely benign.
Frequency
Consequence
NM_018136.5 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ASPM | NM_018136.5 | c.4118_4120delATT | p.Tyr1373del | disruptive_inframe_deletion | 18/28 | ENST00000367409.9 | NP_060606.3 | |
ASPM | NM_001206846.2 | c.4066-8969_4066-8967delATT | intron_variant | NP_001193775.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ASPM | ENST00000367409.9 | c.4118_4120delATT | p.Tyr1373del | disruptive_inframe_deletion | 18/28 | 1 | NM_018136.5 | ENSP00000356379.4 |
Frequencies
GnomAD3 genomes AF: 0.000329 AC: 50AN: 151902Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000391 AC: 97AN: 248016Hom.: 0 AF XY: 0.000416 AC XY: 56AN XY: 134562
GnomAD4 exome AF: 0.000287 AC: 418AN: 1456832Hom.: 0 AF XY: 0.000305 AC XY: 221AN XY: 725018
GnomAD4 genome AF: 0.000329 AC: 50AN: 152020Hom.: 0 Cov.: 32 AF XY: 0.000350 AC XY: 26AN XY: 74316
ClinVar
Submissions by phenotype
Microcephaly 5, primary, autosomal recessive Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Feb 08, 2013 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Nov 11, 2021 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | New York Genome Center | May 29, 2020 | - - |
not provided Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Dec 29, 2016 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 24, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Aug 28, 2024 | Previously reported in a patient with a second ASPM variant, however clinical and segregation information were not provided on this individual (PMID: 33726816); Identified in a patient with a second ASPM variant with global developmental delay and abnormal brain imaging, who also harbored a second pair of variants in a different gene (PMID: 38374194); In-frame deletion of 1 amino acid in a non-repeat region; In silico analysis supports a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 33726816, 38374194) - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 01, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at